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A b s t r a c t
Introduction: Fibromuscular dysplasia (FMD) is an infrequent non-inflamatory disease of unknown etiology that affects mainly 
medium-size arteries. The prevalence of FMD among patients scheduled for endovascular treatment of carotid artery stenosis is 
unknown.
Aim: To evaluate the prevalence and treatment options of carotid FMD in patients scheduled for carotid artery stenting (CAS).
Material and methods: Between Jan 2001 and Dec 2013, 2012 CAS procedures were performed in 1809 patients (66.1% men; 
age 65.3 ±8.4 years, 49.2% symptomatic). In case of FMD suspicion in Doppler-duplex ultrasound (DUS), computed tomography 
angiography was performed for aortic arch and extracranial and intracranial artery imaging. For invasive treatment of FMD carotid 
stenosis, balloon angioplasty was considered first. If the result of balloon angioplasty was not satisfactory (> 30% residual ste-
nosis, dissection), stent placement was scheduled. All patients underwent follow-up DUS and neurological examination 3, 6 and 
12 months after angioplasty, then annually.
Results: There were 7 (0.4%) (4 symptomatic) cases of FMD. The FMD group was younger (47.9 ±7.5 years vs. 67.2 ±8.9 years, 
p = 0.0001), with higher prevalence of women (71.4% vs. 32.7%, p = 0.0422), a higher rate of dissected lesions (57.1% vs. 4.6%, 
p = 0.0002) and less severe stenosis (73.4% vs. 83.9%, p = 0.0070) as compared to the non-FMD group. In the non-FMD group the 
prevalence of coronary artery disease was higher (65.1% vs. 14.3% in FMD group, p = 0.009). All FMD patients underwent successful 
carotid artery angioplasty with the use of neuroprotection devices. In 4 cases angioplasty was supported by stent implantation.
Conclusions: Fibromuscular dysplasia is rare among patients referred for CAS. In case of significant FMD carotid stenosis, it may 
be treated with balloon angioplasty (stent supported if necessary) with optimal immediate and long-term results.
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Introduction
Fibromuscular dysplasia (FMD) is an infrequent 
non-inflammatory disease of unknown etiology that af-
fects mainly medium-size arteries. It usually occurs in 
young women of childbearing age, and in most cases 
renal and carotid arteries are involved. In a large autop-
sy study, FMD was found in 0.02% of > 20000 consec-
utively examined carotid arteries [1]. Although carotid 
FMD is considered by some to be a benign condition, 
in fact, it may lead to serious complications including 
transient ischemic attack/stroke (19.2%), spontaneous 
dissection (19.7%) and aneurysm (17%) [2]. Usually 
FMD lesions can be appreciated in the middle and distal 
segments of the extracervical internal carotid artery, not 
rarely extending to the base of the skull. A typical find-
ing on angiography is multifocal concentric luminal nar-
rowing alternating with areas of mural dilatation that 
are wider than the original lumen (the string-of-beads 
appearance) [3, 4]. This finding is present in 80–90% 
of patients with FMD. Histopathologic findings are ac-
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cumulations of dysplastic muscle cells forming “fibro-
muscular hillocks” and disruption of the internal elastic 
membrane [4]. Macroscopically it leads to microaneu-
rysms and formation of stenotic sections. The preva-
lence of FMD among patients scheduled for endovas-
cular treatment of carotid artery stenosis is unknown. 
With the different etiology and lesion morphology FMD 
may require different treatment strategies as compared 
to atherosclerotic carotid stenosis.
Aim
The aim of the present study was to evaluate the 
prevalence and treatment options of carotid FMD in 
a  population of patients scheduled for carotid artery 
stenting.
Material and methods
Between Jan 2001 and Dec 2013, 2012 carotid artery 
stenting procedures were performed in 1809 patients 
[5, 6]. Doppler-duplex ultrasound (DUS) examination 
and subsequent catheter angiography were procedures 
qualifying for invasive treatment. The FMD DUS criteria 
were: segmental string-of-beads pattern with alternat-
ing regions of lumen narrowing and vessel dilatation 
(morphological criteria); location in the distal extracrani-
al part of the internal carotid artery (ICA); direct and/or 
indirect criteria of stenosis (hemodynamics criterion (op-
tional)) [7]. In case of FMD suspicion computed tomogra-
phy angiography (CTA) was performed for imaging of the 
aortic arch and extracranial and intracranial arteries. For 
atherosclerotic carotid lesions, corresponding guidelines 
were applied for the revascularization strategy. When 
FMD stenosis was confirmed in angiography, the indi-
cations for revascularization were considered individu-
ally. Balloon angioplasty, recommended for symptomat-
ic FMD, was the first line treatment [8]. If the result of 
balloon angioplasty was not satisfactory (> 30% residual 
stenosis, dissection), stent placement was scheduled. All 
patients underwent follow-up DUS and neurological ex-
amination 3, 6 and 12 months after angioplasty, then 
annually. 
Statistical analysis
Patient demographic, clinical, imaging, and procedur-
al data were entered into a database. Univariate analysis 
for between-group comparison was performed. A  two-
tailed t test was used for continuous data, and Fisher’s 
exact test was used for categorical data. A p value < 0.05 
was considered to indicate a statistically significant dif-
ference (Statistica 8.0, StatSoft Inc).
Results
Carotid FMD was found in 7 (0.4%) among 1809 pa-
tients who underwent carotid artery stenting. Patients’ 
characteristics of the FMD group and non-FMD group and 
the comparison between the groups are shown in Table I. 
As expected, the FMD group was younger, with higher 
prevalence of woman. There was also a higher rate of dis-
sected lesions and a slightly lower percentage of stenosis 
in the FMD group as compared to the non-FMD group. 
As the non-FMD group consisted of > 99% atherosclero-
sis-origin lesions, it was not surprising that in this group 
the prevalence of coronary artery disease was much 
higher. All 7 patients with FMD underwent carotid artery 
angioplasty with the use of neuroprotection devices. In 
4 cases angioplasty was supported by stent implantation. 
We present here the three most interesting cases.
Patient 1: A 45-year-old woman with hyperlipidemia 
presented with a 9-day history of left-hemisphere isch-
emic stroke accompanied by right-side hemiparesis and 
motor aphasia. Admission Doppler ultrasound revealed 
left ICA dissection resulting in near-to-occlusion steno-
Table I. Patients’ characteristics (n = 1809)
Characteristics FMD group
n = 7
Non-FMD group 
n = 1802
Value of p
Age, mean ± range [years] 47.9 ±7.5 (45–63) 67.2 ±8.9 (36–88) 0.0001
Female, n (%) 5 (71.4) 589 (32.7) 0.0422 
Prior neurological symptoms*, n (%) 4 (57.1) 894 (49.6) 0.7242
Arterial hypertension, n (%) 7 (100) 1648 (91.5) 1.000
Hyperlipidemia, n (%) 5 (71.4) 1338 (74.3) 1.000
Smoking (current, h/o), n (%) 4 (57.1) 820 (45.5) 0.7087
Diabetes, n (%) 1 (14.3) 514 (28.5) 0.6806
Coronary artery disease, n (%) 1 (14.3) 1174 (65.1) 0.009
History of myocardial infarction, n (%) 1 (14.3) 475 (26.4) 0.6835
Contralateral ICA involved, n (%) 1 (14.3) 593 (32.9) 0.4375
% stenosis (SD) 73.4 ±18.6 83.9 ±2.75 0.0070
Local dissection, n (%) 4 (57.1) 83 (4.6) 0.0002
*Within 6 months prior to CAS. 
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Figure 1. A 45-year-old woman with hyperlipidemia presented with a 9-day history of left-hemisphere ischemic 
stroke accompanied by right-side hemiparesis and motor aphasia with LICA critical stenosis. A, B, C – CT angio-
graphy. A – Spherical left ICA aneurysm (9 × 8 mm) with short artery dissection causing near-to-occlusion ste-
nosis at the distal top of the aneurysm at C1 level. B – Right ICA irregular lumen stenosis with ‘string-of-beads’ 
morphology typical for fibromuscular dysplasia. C – Small (3.6 × 2.8 mm) aneurysm of anterior communicating 
cerebral artery. D, E, F – catheter angiography. D – subtotal LICA stenosis confirmed by angiography. E – Precise 
6 × 30 mm self-expanding open-cell stent positioning. F – optimal angiographic result of LICA-CAS
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sis with low peak systolic (0.4  m/s) and end diastolic 
(0.25 m/s) velocities, a delay in systolic acceleration and 
markedly narrowed artery lumen distally to the stenosis 
site. Subsequent CTA revealed spherical left ICA (LICA) 
aneurysm (9 × 8 mm) with short artery dissection caus-
ing near-to-occlusion stenosis at the distal top of the 
aneurysm at C1 level (Figure 1 A). Right ICA (RICA) had 
irregular lumen stenosis with ‘string-of-beads’ morphol-
ogy typical for FMD (Figure 1 B). Intracranial CTA showed 
a  small (3.6 × 2.8 mm) aneurysm of the anterior com-
municating cerebral artery (Figure 1 C). After neurological 
consultation, the patient was referred for urgent carot-
id artery angioplasty. The left side carotid angiography 
is shown in Figure 1 D. Directly after angiography LICA 
distal neuroprotected (Spider FX, ev3 Inc., Plymouth, MN, 
USA) angioplasty was performed with a  4.0 × 20  mm 
balloon. Suboptimal, 40% residual stenosis was treated 
with a self-expanding open-cell stent (Precise 6 × 30 mm, 
Cordis, a Johnson & Johnson company, Miami Lakes, FL, 
USA) (Figure 1 E). No postdilatation was required, and 
the final result was optimal (Figure 1 F). The periproce-
dural and postprocedural period was uneventful. For the 
next 42 months of follow-up she has not demonstrated 
any new neurological symptoms and DUS evaluation has 
not indicated in-stent restenosis or significant right ICA 
stenosis progression.
Patient 2: A  63-year-old female patient with hyper-
tension and a history of ST elevation anterior myocardial 
infarction (MI) presented with asymptomatic bilateral ca-
rotid bruit and CCS 3 angina for further non-invasive and 
invasive evaluation. Admission DUS showed bilateral ICA 
stenosis with peak systolic velocity/end diastolic velocity 
(PSV/EDV) of 1.5/0.6 m/s on the left side and PSV/EDV 
of 3.1/1.3 m/s on the right side (> 80% stenosis accord-
ing to the Bluth criteria). Interestingly, 6 months earlier 
RICA PSV/EDV were 1.9/0.9 m/s. Figures 2 A and B show 
CTA images of RICA. Despite the asymptomatic status, 
the multidisciplinary team members decided to qualify 
the patient for carotid artery angioplasty due to severe 
disease progression revealed in DUS. Coronarography re-
vealed no coronary artery disease. Angiography confirmed 
significant RICA stenosis caused by FMD (Figure 2 C). 
With distal neuroprotection (FilterWire EZ, Boston Scien-
tific, Natick, MA, USA), angioplasty with a 4.0 × 20 mm 
balloon was performed (Figure 2 D). The immediate re-
sult was optimal, and no stent implantation was required 
(Figure 2 E). The periprocedural and postprocedural peri-
od was uneventful. For the next 36 months of follow-up 
the patient has remained neurologically asymptomatic 
with a preserved RICA angioplasty effect and stable LICA 
image in DUS.
Patient 3: A 51-year-old male patient with hyperten-
sion, chronic renal insufficiency and a history of left-side 
ischemic stroke 5 months earlier, after CAS performed due 
to string-sign (not typical for FMD) LICA stenosis 3 weeks 
earlier, was admitted for scheduled RICA-CAS. RICA 70% 
stenosis was revealed during previous hospitalization, 
and it was confirmed in CT-angiography (Figures 3 A, B). 
Figure 3 C shows angiography of RICA performed directly 
before CAS. Long, irregular artery stenosis in its distal ex-
tracranial segment supported the diagnosis of FMD. With 
proximal neuroprotection (Mo.Ma 8F, Invatec, Roncadelle, 
Italy), angioplasty with a 4.0 × 20 mm balloon (Figure 3 D), 
supported with self-expanding open-cell stent implanta-
tion (Precise 9.0 × 40 mm), was performed. The stent was 
postdilated with a 4.5 × 20 mm balloon (Figure 3 E). The 
periprocedural and postprocedural period was unevent-
ful, as was 14-month follow-up.
Discussion
The present study indicates that FMD is rare in pa-
tients with carotid artery stenosis scheduled for endo-
vascular intervention, in our series 0.4%. This proportion 
is lower than that reported by de Monyé et al. (0.5%), 
who used computed tomography (CT) angiography as 
a screening tool [9]. It must be noted, however, that, in 
contrast to our group, they examined only neurological-
ly symptomatic patients. The results of epidemiological 
studies indicate that multiple FMD lesions may be ob-
served in the same patient including not only carotid and 
renal arteries but also intracranial circulation. The pres-
ence of intracranial aneurysms was reported by Stanley 
in 41% of patients with internal carotid artery FMD [10]. 
Similar results were reported by Frens, who confirmed 
intracranial aneurysms in 21% of patients referred for 
angiography due to cervical arterial FMD [11]. The prev-
alence of intracranial aneurysm in our group was 14% 
(1 out of 7). Endovascular FMD treatment requires admin-
istration of antiplatelet drugs including aspirin, clopido-
grel and heparin periprocedurally. Thus, it is of key impor-
tance to perform angiography of both extracranial and 
intracranial arteries to evaluate the risk of endovascular 
intervention including the risk of periprocedural intra-
cranial bleeding, which is significantly higher in patients 
with intracranial aneurysm. If there is a satisfactory bal-
loon angioplasty effect, when stent implantation may be 
discarded, clopidogrel continuation is not necessary, and 
thus the risk of bleeding complications may be limited. 
Considering the high degree of coexistence of intracrani-
al aneurysm and FMD, some advocate performing mag-
netic resonance imaging (MRI) of the cerebral circulation 
in every patient with FMD [12]. Although coronary an-
giograms in all patients did not reveal any abnormali-
ties, patient no. 2 had a history of myocardial infarction 
confirmed by echocardiography on admission. This may 
support the observation of Saw et al., who found FMD in 
86% of cases among spontaneous coronary artery dissec-
tion patients presenting with myocardial infarction [13]. 
It was also reported that most patients with FMD and MI 
have left anterior descending artery (LAD) involved [14]. 
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Figure 2. A 63-year-old female patient with hypertension and history of ST elevation anterior myocardial infarc-
tion presented with bilateral, asymptomatic ICA stenosis. A, B – CT angiography. A – 3D aortic arch reconstruc-
tion. B – vertical section of proximal RICA showing focal critical artery narrowing (arrow). C, D, E – catheter an-
giography. C – significant RICA stenosis caused by FMD. D – angioplasty with 4.0 × 20 mm balloon with a distal 
neuroprotection system. E – optimal immediate result of balloon angioplasty, no need for stent implantation
A B
C D E
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Figure 3. A 51-year-old male patient presented with hypertension, chronic renal insufficiency and history of 
ischemic stroke 5 months earlier, after CAS performed due to string-sign (not typical for FMD) LICA stenosis  
3 weeks earlier admitted for scheduled RICA-CAS. A, B – 3D and 2D reconstructions in CT angiography showing 
long, irregular significant RICA stenosis. C, D, E – catheter angiography. C – significant RICA stenosis in its distal 
extracranial segment. D – proximal neuroprotected (Mo.Ma 8 Fr) angioplasty with 4.0 × 20 mm balloon, sup-
ported with self-expanding open-cell stent implantation (Precise 9.0 × 40 mm, postdilated with 4.5 × 20 mm 
balloon). E – optimal RICA-CAS result
A
C D E
B
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The apical aneurysm in echocardiography in our patient 
suggests the same pattern of coronary FMD. 
For FMD detection DUS seems to be the best screen-
ing tool as non-invasive, safe and easily accessible. How-
ever, the ultrasonographer should keep in mind that typ-
ically FMD lesions, as opposed to atherosclerotic ones, 
are located at the level of the C1-C2 vertebra, and can be 
overlooked [15]. Thus, it is important to scan the carotid 
artery as distally as possible, and in case of doubt, fur-
ther non-invasive evaluation should be considered. Both 
CT and MRI angiography have very good accuracy for de-
tection of stenotic segments as well as other vascular 
pathologies accompanying FMD [16]. 
The endovascular treatment of symptomatic carotid 
stenosis provoked by FMD has been reported to be an 
effective and safe procedure [17]. It is unknown wheth-
er patients with symptomatic FMD are at higher risk of 
periprocedural complications as it may be observed in 
CAS for atherosclerotic origin stenosis [6, 18].
All patients described in this work had an unevent-
ful periprocedural and postprocedural course, and good 
patency of angioplasty was established in > 24-month 
follow-up. 
Conclusions
Fibromuscular dysplasia is rare among patients re-
ferred for carotid artery angioplasty. In the case of sig-
nificant FMD stenosis, it may be treated with carotid 
angioplasty (stent supported if necessary) with optimal 
immediate and long-term results. 
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